 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase, hydrolase
|
PDB id
|
|
|
|
1thz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.1.2.3
- Phosphoribosylaminoimidazolecarboxamide formyltransferase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Purine Biosynthesis (late stages)
|
 |
 |
 |
 |
 |
Reaction:
|
 |
10-formyltetrahydrofolate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4- carboxamide = tetrahydrofolate + 5-formamido-1-(5-phospho-D- ribosyl)imidazole-4-carboxamide
|
 |
 |
 |
 |
 |
10-formyltetrahydrofolate
|
+
|
5-amino-1-(5-phospho-D-ribosyl)imidazole-4- carboxamide
|
=
|
tetrahydrofolate
|
+
|
5-formamido-1-(5-phospho-D- ribosyl)imidazole-4-carboxamide
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.5.4.10
- Imp cyclohydrolase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
IMP + H2O = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide
|
 |
 |
 |
 |
 |
IMP
|
+
|
H(2)O
|
=
|
5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
mitochondrion
|
1 term
|
 |
|
Biological process
|
metabolic process
|
3 terms
|
 |
|
Biochemical function
|
catalytic activity
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:50555-50565
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening.
|
|
L.Xu,
C.Li,
A.J.Olson,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aminoimidazole-4-carboxamide ribonucleotide transformylase (AICAR Tfase), one of
the two folate-dependent enzymes in the de novo purine biosynthesis pathway, is
a promising target for anti-neoplastic chemotherapy. Although classic
antifolates, such as methotrexate, have been developed as anticancer agents,
their general toxicity and drug resistance are major issues associated with
their clinical use and future development. Identification of inhibitors with
novel scaffolds could be an attractive alternative. We present here the crystal
structure of avian AICAR Tfase complexed with the first non-folate based
inhibitor identified through virtual ligand screening of the National Cancer
Institute Diversity Set. The inhibitor 326203-A
(2-[5-hydroxy-3-methyl-1-(2-methyl-4-sulfophenyl)-1H-pyrazol-4-ylazo]-4-sulfo-benzoic
acid) displayed competitive inhibition against the natural cofactor,
10-formyl-tetrahydrofolate, with a K(i) of 7.1 mum. The crystal structure of
AICAR Tfase with 326203-A at 1.8 A resolution revealed a unique binding mode
compared with antifolate inhibitors. The inhibitor also accessed an additional
binding pocket that is not occupied by antifolates. The sulfonate group of
326203-A appears to form the dominant interaction of the inhibitor with the
proposed oxyanion hole through interaction with a helix dipole and Lys(267). An
aromatic interaction with Phe(316) also likely contributes to favorable binding.
Based on these structural insights, several inhibitors with improved potency
were subsequently identified in the National Cancer Institute Compound Library
and the Available Chemical Directory by similarity search and molecular modeling
methods. These results provide further support for our combined virtual ligand
screening rational design approach for the discovery of novel, non-folate-based
inhibitors of AICAR Tfase.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Chemical structures of inhibitor 326203-A and the
active site of AICAR Tfase. A, the structure of 326203-A is
shown as depicted in National Cancer Institute Compound library;
the Cr^3+ chelation site is highlighted in red. B, the crystal
structure of the inhibitor did not show any bound Cr^3+ but
instead an intramolecular hydrogen bond array, which is colored
in red. C, stereo view of the AICAR Tfase active site with bound
326203-A. The two different subunits of the dimer that compose
the active site are colored in sky blue and pink, respectively.
The bound inhibitor is depicted in ball-and-stick
representation, with the oxygen atoms in red, carbons in yellow,
sulfurs in green, and nitrogens in blue. The 2F[o] - F[c]
electron density map (blue) for the inhibitor is contoured at
1.0 . The key interactions
of the inhibitor with AICAR Tfase involve three moieties of the
inhibitor: benzene ring A, pyrazole ring, and benzene ring B.
|
 |
Figure 4.
FIG. 4. AICAR Tfase-326203-A interactions. A, residues in
the AICAR Tfase active site interact with the inhibitor. The
side chains of the protein and the inhibitor are depicted in
ball-and-stick representations. The protein and inhibitor are
colored as in Fig. 2C. The side chains of the protein are
colored in gray. Asn^490 has a different conformation in the apo
human enzyme and is colored in green. B, schematic drawing of
AICAR Tfase interactions with 326203-A, generated by LIGPLOT
(31). Residues forming van der Waals' interactions are indicated
by an arc with radiating spokes toward the ligand atom they
contact; those participating in the hydrogen bonding are shown
in ball-and-stick representations. Hydrogen bonds are
illustrated as dotted lines with the donor-acceptor distance
given in Å. Water molecules are colored in cyan, and
carbon atoms are in black; other atom types are colored
according to Fig. 2C.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
50555-50565)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Zhang,
M.Morar,
and
S.E.Ealick
(2008).
Structural biology of the purine biosynthetic pathway.
|
| |
Cell Mol Life Sci, 65,
3699-3724.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|